{{Rsnum
|rsid=2002842
|Chromosome=18
|position=76409597
|Orientation=plus
|GMAF=0.4858
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 15.7 | 60.2 | 24.1
| HCB | 68.6 | 29.2 | 2.2
| JPT | 67.3 | 29.1 | 3.6
| YRI | 10.1 | 37.4 | 52.5
| ASW | 12.3 | 36.8 | 50.9
| CHB | 68.6 | 29.2 | 2.2
| CHD | 76.1 | 22.9 | 0.9
| GIH | 25.8 | 47.4 | 26.8
| LWK | 8.6 | 43.8 | 47.6
| MEX | 31.6 | 42.1 | 26.3
| MKK | 0.0 | 0.0 | 0.0
| TSI | 19.4 | 52.0 | 28.6
| HapMapRevision=28
}}{{GWAS Summary
|SNP=rs2002842
|PubMedID=18668548
|Condition=Rheumatoid arthritis
|Gene=SALL3
|Risk Allele=A
|pValue=6.00E-006
|OR=1.61
|95CI=
}}

{{PharmGKB
|RSID=rs2002842
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:18668548; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS Results: Genome-wide association study of rheumatoid arthritis in the Spanish population: KLF12 as a risk locus for rheumatoid arthritis susceptibility (Initial Sample Size: 400 cases, 400 controls; Replication Sample Size: 410 cases, 394 controls; Risk Allele: rs2002842-A). This variant is associated with Rheumatoid arthritis.
|Drugs=
|Drug Classes=
|Diseases=Arthritis, Rheumatoid
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356512
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2002842
|overall_frequency_n=46
|overall_frequency_d=122
|overall_frequency=0.377049
|n_genomes=30
|n_genomes_annotated=0
|n_haplomes=40
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}